Cannabis litigation landscape; plummeting smartphone sales; Nokia offers arbitration to Oppo; quarterly litigation report; Deutsche Telekom on EPO transparency; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

MONDAY 06 February

IAM’s lowdown on the fast-evolving cannabis patent dispute landscape. Read more here

Haynes and Boone bags most wins for PTAB petitioners while McKool Smith scores for patentees. Read more here

TUESDAY 07 February

A Delaware jury has ordered Boston Scientific to pay $42 million in damages to the University of Texas and its licensee, TissueGen, for wilful infringement of a US patent. Read more here

Smartphone sales plummet causing pain for SEP licensors. Read more here

WEDNESDAY 08 February

IAM exclusive: Nokia makes arbitration offer to Oppo in bid to resolve 5G dispute. Read more here

Long read: Patent strategies for protecting bioinformatics inventions. Read more here

Oppo joins Via Licensing’s AAC patent pool. Read more here

THURSDAY 09 February

Patent litigation finance works: no wonder some want it curtailed. Read more here

Greater transparency needed at the EPO, says Deutsche Telekom’s patent chief. Read more here

In the latest IAM-Docket Navigator litigation report, we examine the drastic impact of US Patent and Trademark Office Director Kathi Vidal’s policies on discretionary denials. Read more here

FRIDAY 10 February

InterDigital patent found valid on appeal by UK court in Lenovo licensing spat. Read more here

Long read: In a preview of IAM’s upcoming special report we offer insights from industry-leading IP organisations on putting diversity initiatives into action. Read more here

SEP holders hotly contest Stout’s ‘SEP privateer’ report. Read more here

SATURDAY 11 February

Opinion: Authenticity is key when it comes to brand sustainability. Read more here



Unlock unlimited access to all IAM content